FindTrial
Sign In

Study on risk factors of invasive mold disease (IMD) in patients with hematological malignancies undergoing chemotherapy and its prediction model

Study on risk factors of invasive mold disease (IMD) in patients with hematological malignancies undergoing chemotherapy and its prediction model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067844
Enrollment
Unknown
Registered
2023-01-29
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

invasive mold disease

Interventions

Case series:N/A

Sponsors

Department of Hematology, Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Hospitalized patients with hematological malignancies undergoing chemotherapy from 2015 January to 2020 January; 2. Aede over 18 years.

Exclusion criteria

Exclusion criteria: 1. Patients with hospitalization shorter than 2 days; 2. Those who have been diagnosed or clinically diagnosed as IMD and patients who have initiated antifungal therapy when at admission.

Design outcomes

Primary

MeasureTime frame
incidences of invasive mold disease (IMD);—

Secondary

MeasureTime frame
positive predictive value;negative predictive value;—

Countries

China

Contacts

Public ContactMinghui Duan

Peking Union Medical College Hospital

mhduan@sina.com+86 136 2126 2462

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026